Your browser doesn't support javascript.
loading
Hepatitis B virus-specific CD4 T cell responses differentiate functional cure from chronic surface antigen+ infection.
Hoogeveen, Ruben C; Dijkstra, Suzan; Bartsch, Lea M; Drescher, Hannah K; Aneja, Jasneet; Robidoux, Maxwell P; Cheney, James A; Timm, Joerg; Gehring, Adam; de Sousa, Paulo Sergio Fonseca; Ximenez, Lya; Peliganga, Luis Baiao; Pitts, Anita; Evans, Fiona B; Boonstra, André; Kim, Arthur Y; Lewis-Ximenez, Lia L; Lauer, Georg M.
  • Hoogeveen RC; Division of Gastroenterology, Massachusetts General Hospital and Harvard Medical School, Boston, USA; Department of Gastroenterology and Hepatology, Erasmus MC, University Medical Center, Rotterdam, the Netherlands.
  • Dijkstra S; Division of Gastroenterology, Massachusetts General Hospital and Harvard Medical School, Boston, USA.
  • Bartsch LM; Division of Gastroenterology, Massachusetts General Hospital and Harvard Medical School, Boston, USA.
  • Drescher HK; Division of Gastroenterology, Massachusetts General Hospital and Harvard Medical School, Boston, USA.
  • Aneja J; Division of Gastroenterology, Massachusetts General Hospital and Harvard Medical School, Boston, USA; Division of Infectious Diseases, Massachusetts General Hospital and Harvard Medical School, Boston, USA.
  • Robidoux MP; Division of Gastroenterology, Massachusetts General Hospital and Harvard Medical School, Boston, USA.
  • Cheney JA; Division of Gastroenterology, Massachusetts General Hospital and Harvard Medical School, Boston, USA.
  • Timm J; Institute of Virology, Heinrich Heine University, University Hospital, Düsseldorf, Germany.
  • Gehring A; Toronto Centre for Liver Disease, Toronto General Hospital Research Institute, University Health Network, Toronto, Ontario, Canada; Department of Immunology, University of Toronto, Toronto, Ontario, Canada.
  • de Sousa PSF; Instituto Oswaldo Cruz, Fundação Oswaldo Cruz, Rio de Janeiro, Brazil.
  • Ximenez L; Instituto Oswaldo Cruz, Fundação Oswaldo Cruz, Rio de Janeiro, Brazil.
  • Peliganga LB; Instituto Oswaldo Cruz, Fundação Oswaldo Cruz, Rio de Janeiro, Brazil; Faculdade de Medicina da Universidade Agostinho Neto, Luanda, Angola; Ministério da Saúde de Angola, Luanda, Angola.
  • Pitts A; Division of Gastroenterology, Massachusetts General Hospital and Harvard Medical School, Boston, USA.
  • Evans FB; Division of Gastroenterology, Massachusetts General Hospital and Harvard Medical School, Boston, USA.
  • Boonstra A; Department of Gastroenterology and Hepatology, Erasmus MC, University Medical Center, Rotterdam, the Netherlands.
  • Kim AY; Division of Infectious Diseases, Massachusetts General Hospital and Harvard Medical School, Boston, USA.
  • Lewis-Ximenez LL; Instituto Oswaldo Cruz, Fundação Oswaldo Cruz, Rio de Janeiro, Brazil.
  • Lauer GM; Division of Gastroenterology, Massachusetts General Hospital and Harvard Medical School, Boston, USA. Electronic address: glauer@mgh.harvard.edu.
J Hepatol ; 77(5): 1276-1286, 2022 11.
Article en En | MEDLINE | ID: mdl-35716846
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Hepatitis B Crónica / Hepatitis B Límite: Humans Idioma: En Año: 2022 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Hepatitis B Crónica / Hepatitis B Límite: Humans Idioma: En Año: 2022 Tipo del documento: Article